StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.76+0.00 (+0.07%)

Close on Nov 17, 2026Market cap $34.21MP/E –Yield –

TELA Bio cash

Cash and short-term investments held at the end of each period.

TELA Bio's cash was $30.42M at Jun 30, 2026. For fiscal 2025 it was $50.85M, down 3.9% from the year before. The highest annual figure on record is $74.39M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$50.85M-3.9%
FY2024Dec 31, 2024$52.94M+12.6%
FY2023Dec 31, 2023$46.99M+11.8%
FY2022Dec 31, 2022$42.02M-4.4%
FY2021Dec 31, 2021$43.93M-40.9%
FY2020Dec 31, 2020$74.39M+36.3%
FY2019Dec 31, 2019$54.59M+215.9%
FY2018Dec 31, 2018$17.28M+52.3%
FY2017Dec 31, 2017$11.35M+666.6%
FY2016Dec 31, 2016$1.48M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$30.42M-13.0%
Q1 FY2026Mar 31, 2026$39.54M-7.7%
Q4 FY2025Dec 31, 2025$50.85M-3.9%
Q3 FY2025Sep 30, 2025$29.71M+71.7%
Q2 FY2025Jun 30, 2025$34.98M+32.0%
Q1 FY2025Mar 31, 2025$42.83M+15.3%
Q4 FY2024Dec 31, 2024$52.94M+12.6%
Q3 FY2024Sep 30, 2024$17.30M-70.3%
Q2 FY2024Jun 30, 2024$26.50M-59.4%
Q1 FY2024Mar 31, 2024$37.14M+23.3%
Q4 FY2023Dec 31, 2023$46.99M+11.8%
Q3 FY2023Sep 30, 2023$58.20M+7.3%
Q2 FY2023Jun 30, 2023$65.27M+135.4%
Q1 FY2023Mar 31, 2023$30.12M-8.8%
Q4 FY2022Dec 31, 2022$42.02M-4.4%
Q3 FY2022Sep 30, 2022$54.23M+1.1%
Q2 FY2022Jun 30, 2022$27.73M-54.0%
Q1 FY2022Mar 31, 2022$33.02M-49.8%
Q4 FY2021Dec 31, 2021$43.93M-40.9%
Q3 FY2021Sep 30, 2021$53.64M-34.2%
Q2 FY2021Jun 30, 2021$60.29M-29.5%
Q1 FY2021Mar 31, 2021$65.83M+41.0%
Q4 FY2020Dec 31, 2020$74.39M+36.3%
Q3 FY2020Sep 30, 2020$81.47M+413.2%
Q2 FY2020Jun 30, 2020$85.47M+806.2%
Q1 FY2020Mar 31, 2020$46.70M+170.3%
Q4 FY2019Dec 31, 2019$54.59M+2753.5%
Q2 FY2019Jun 30, 2019$15.87M+39.9%
Q1 FY2019Mar 31, 2019$9.43M+537.3%
Q4 FY2018Dec 31, 2018$17.28M–
Q3 FY2018Sep 30, 2018$1.91M–
Q4 FY2017Dec 31, 2017$11.35M–
Q4 FY2016Dec 31, 2016$1.48M–

More TELA Bio figures

See a number that looks wrong?